Your browser doesn't support javascript.
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies.
Gambacorti-Passerini, Carlo; Ruggeri, Marco; Aroldi, Andrea; Piazza, Rocco; Mazzi, Angela; De Silvestro, Giustina; Krampera, Mauro; Lanza, Francesco.
  • Gambacorti-Passerini C; University of Milano-Bicocca, Monza, Italy; Hematology Division, ASST Monza, Italy. Electronic address: carlo.gambacorti@unimib.it.
  • Ruggeri M; Division of Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Aroldi A; University of Milano-Bicocca, Monza, Italy; Hematology Division, ASST Monza, Italy.
  • Piazza R; University of Milano-Bicocca, Monza, Italy; Hematology Division, ASST Monza, Italy.
  • Mazzi A; Transfusion Medicine Unit, Azienda USL-IRCCS, Reggio Emilia, Italy.
  • De Silvestro G; Blood Transfusion Service, Apheresis Unit, University Hospital of Padova, Italy.
  • Krampera M; Section of Hematology, Department of Medicine, University of Verona, Policlinico G.B. Rossi, Verona, Italy.
  • Lanza F; Hematology Service, Hospital of Ravenna, Ravenna, Italy.
Transfus Apher Sci ; 60(3): 103105, 2021 06.
Article in English | MEDLINE | ID: covidwho-1091619
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Donors / Blood Transfusion / Hematologic Neoplasms / COVID-19 Limits: Female / Humans / Male Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Donors / Blood Transfusion / Hematologic Neoplasms / COVID-19 Limits: Female / Humans / Male Language: English Journal: Transfus Apher Sci Journal subject: Hematology Year: 2021 Document Type: Article